Formycon Reports First Quarter 2022 Financial Results and Announces Development Start of two New Bio
DGAP-News: Formycon AG / Key word(s): Quarter ResultsFormycon Reports First Quarter 2022 Financial Results and Announces Development Start of two New Biosimilar Candidates FYB208 and FYB209 21.06.2022 / 07:30 The issuer is solely responsible for the content of this announcement.Press Release // June 21, 2022Formycon...
Source: pharmiweb.com
